Aeterna Zentaris Inc. has undergone a major transformation, rebranding itself as COSCIENS Biopharma Inc. This corporate transition reflects not only a nominal change but also a strategic overhaul aimed at better representing the company's diversified portfolio and innovative drive within the
Freudenberg Medical, known for its contributions to biopharmaceuticals and medical devices, continues to enhance its product offerings and global footprint. Highlighted in an August 2024 article by Feliza Mirasol, the company's business expansion strategy focuses on custom single-use
In a significant milestone for the biopharmaceutical industry, AGC Biologics' Seattle site successfully underwent a multi-product inspection by the U.S. Food and Drug Administration (FDA) in March 2024. This comprehensive evaluation was aimed at supporting Biologics License Applications (BLA)
The biopharmaceutical and life sciences industry is experiencing dynamic shifts, marked by strategic partnerships, innovative laboratory products, and enhanced service offerings. Companies are increasingly focusing on forming alliances, introducing state-of-the-art equipment, and improving their
In a recent strategic maneuver, Myriad Genetics, Inc., known for its pioneering work in genetic testing and precision medicine, officially announced the sale of its EndoPredict business unit to Eurobio Scientific. Based in Salt Lake City, Utah, Myriad's decision aligns with broader plans to
Global Automation in Biopharma Market to Surge by 2031: Key Trends and Forecasts The global biopharma market is on the cusp of remarkable transformations driven by automation, enabling more efficient production processes and improved product quality. This evolving sector is undergoing significant
